Market Cap ₹4 Cr.
Stock P/E 4.4
P/B 0.1
Current Price ₹3.6
Book Value ₹ 27.4
Face Value 10
52W High ₹0
Dividend Yield 0%
52W Low ₹ 0
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 7 | 18 | 18 | 4 | 21 | 21 | 11 | 10 | 19 | 10 |
Other Income | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Income | 7 | 19 | 18 | 4 | 21 | 21 | 11 | 11 | 19 | 10 |
Total Expenditure | 6 | 18 | 17 | 4 | 20 | 20 | 10 | 10 | 18 | 10 |
Operating Profit | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 0 |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 1 | 0 | -0 | -0 | 0 | 0 | 0 | 0 | 0 | -0 |
Provision for Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Tax | 1 | 0 | -0 | -0 | 0 | 0 | 0 | 0 | 0 | -0 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 |
Profit After Adjustments | 1 | 0 | -0 | -0 | 0 | 0 | 0 | 0 | 0 | -0 |
Adjusted Earnings Per Share | 0.5 | 0.1 | -0.4 | -0.2 | 0 | 0.1 | 0.1 | 0 | 0.4 | -0.2 |
#(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | TTM |
---|---|---|---|---|---|---|---|
Net Sales | 32 | 39 | 35 | 40 | 45 | 40 | 50 |
Other Income | 1 | 1 | 1 | 2 | 1 | 1 | 0 |
Total Income | 33 | 40 | 36 | 41 | 46 | 41 | 51 |
Total Expenditure | 30 | 37 | 33 | 38 | 43 | 39 | 48 |
Operating Profit | 3 | 2 | 3 | 3 | 3 | 3 | 3 |
Interest | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 2 | 1 | 2 | 2 | 1 | 0 | 0 |
Provision for Tax | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
Profit After Tax | 1 | 0 | 1 | 2 | 0 | 0 | 0 |
Adjustments | -0 | -0 | -0 | -0 | -0 | 0 | 0 |
Profit After Adjustments | 1 | 0 | 1 | 1 | 0 | 0 | 0 |
Adjusted Earnings Per Share | 1.1 | 0.2 | 0.6 | 0.8 | 0.1 | 0 | 0.3 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | -11% | 5% | 5% | 0% |
Operating Profit CAGR | 0% | 0% | 0% | 0% |
PAT CAGR | 0% | -100% | -100% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 0% | -3% | 3% | -14% |
ROE Average | 1% | 3% | 3% | 4% |
ROCE Average | 5% | 6% | 6% | 7% |
#(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 |
---|---|---|---|---|---|---|
Shareholder's Funds | 17 | 25 | 25 | 26 | 23 | 23 |
Minority's Interest | 10 | 12 | 11 | 13 | 11 | 11 |
Borrowings | 2 | 0 | 4 | 4 | 5 | 6 |
Other Non-Current Liabilities | 0 | 1 | 1 | 1 | 1 | 3 |
Total Current Liabilities | 10 | 8 | 21 | 16 | 36 | 53 |
Total Liabilities | 38 | 45 | 63 | 60 | 76 | 95 |
Fixed Assets | 5 | 7 | 7 | 9 | 9 | 8 |
Other Non-Current Assets | 7 | 18 | 17 | 21 | 15 | 28 |
Total Current Assets | 26 | 21 | 40 | 30 | 51 | 59 |
Total Assets | 38 | 45 | 63 | 60 | 76 | 95 |
#(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 |
---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 0 | 1 | 2 | 2 | 3 | 2 |
Cash Flow from Operating Activities | 0 | -0 | -6 | 3 | -2 | -1 |
Cash Flow from Investing Activities | 0 | -9 | 3 | -2 | 8 | -1 |
Cash Flow from Financing Activities | 0 | 11 | 3 | -1 | -7 | 1 |
Net Cash Inflow / Outflow | 0 | 2 | 0 | 0 | -1 | -1 |
Closing Cash & Cash Equivalent | 0 | 2 | 2 | 3 | 2 | 1 |
# | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 |
---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 1.11 | 0.22 | 0.62 | 0.83 | 0.12 | 0.05 |
CEPS(Rs) | 2.64 | 0.9 | 1.46 | 1.7 | 1.16 | 1.06 |
DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 |
Book NAV/Share(Rs) | 18.11 | 20.46 | 20.76 | 21.64 | 18.69 | 18.95 |
Core EBITDA Margin(%) | 7.2 | 3.29 | 4.67 | 3.8 | 3.83 | 4 |
EBIT Margin(%) | 7.36 | 4.47 | 6.82 | 6.94 | 3.8 | 3.88 |
Pre Tax Margin(%) | 5.53 | 2.63 | 4.54 | 4.33 | 1.34 | 1.09 |
PAT Margin (%) | 4.01 | 0.93 | 3.49 | 3.79 | 0.96 | 0.66 |
Cash Profit Margin (%) | 5.99 | 2.8 | 5.04 | 5.18 | 3.15 | 3.15 |
ROA(%) | 3.33 | 0.86 | 2.25 | 2.44 | 0.63 | 0.31 |
ROE(%) | 9.77 | 1.91 | 4.9 | 5.88 | 1.76 | 1.17 |
ROCE(%) | 10.29 | 6.69 | 7.67 | 8.07 | 5.09 | 4.77 |
Receivable days | 158.93 | 134.79 | 227.25 | 220.6 | 256.34 | 427.9 |
Inventory Days | 29.75 | 22.1 | 38.28 | 57.65 | 47.81 | 39.6 |
Payable days | 47.69 | 22.13 | 304.32 | 345.18 | 255.6 | 298.66 |
PER(x) | 49.21 | 240.41 | 72.01 | 3.94 | 39.61 | 89.28 |
Price/Book(x) | 3.01 | 2.54 | 2.16 | 0.15 | 0.25 | 0.22 |
Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | 1.36 | 1.67 | 1.72 | 0.25 | 0.29 | 0.37 |
EV/Core EBITDA(x) | 14.61 | 26.37 | 20.51 | 3.02 | 4.88 | 5.88 |
Net Sales Growth(%) | 0 | 20.82 | -9.57 | 13.71 | 12.4 | -9.2 |
EBIT Growth(%) | 0 | -26.67 | 38.04 | 15.64 | -38.45 | -7.29 |
PAT Growth(%) | 0 | -71.88 | 237.67 | 23.56 | -71.58 | -37.96 |
EPS Growth(%) | 0 | -80.49 | 187.29 | 32.83 | -85.66 | -61.4 |
Debt/Equity(x) | 0.43 | 0.16 | 0.33 | 0.34 | 0.4 | 0.5 |
Current Ratio(x) | 2.67 | 2.58 | 1.85 | 1.9 | 1.44 | 1.12 |
Quick Ratio(x) | 2.4 | 2.33 | 1.61 | 1.65 | 1.31 | 1.03 |
Interest Cover(x) | 4.02 | 2.43 | 2.99 | 2.66 | 1.55 | 1.39 |
Total Debt/Mcap(x) | 0.14 | 0.06 | 0.15 | 2.24 | 1.61 | 2.32 |
# | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 2.45 | 2.45 | 2.45 | 2.45 | 2.45 | 2.45 | 2.45 | 2.45 | 2.45 | 2.45 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 97.55 | 97.55 | 97.55 | 97.55 | 97.55 | 97.55 | 97.55 | 97.55 | 97.55 | 97.55 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 1.18 | 1.18 | 1.18 | 1.18 | 1.18 | 1.18 | 1.18 | 1.18 | 1.18 | 1.18 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1.21 | 1.21 | 1.21 | 1.21 | 1.21 | 1.21 | 1.21 | 1.21 | 1.21 | 1.21 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About